尔康制药 (300267.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(尔康制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 275,789,340.201,783,118,780.921,445,366,591.951,050,160,519.66546,925,468.791,870,540,810.781,317,388,175.56870,551,135.58426,347,681.19
 营业利润(元) 838,832.93-206,725,851.9835,816,355.5048,595,924.9318,917,822.6413,779,914.2445,513,619.3640,394,501.9221,162,595.33
 利润总额(元) 748,003.27-198,932,851.0341,306,414.7553,666,396.9220,861,989.1617,354,194.3849,091,648.8341,057,304.8521,741,496.78
 净利润(元) -285,701.09-221,853,783.7423,962,311.3541,118,711.8020,455,494.1636,890,803.0530,294,249.4427,145,571.9219,785,501.01
 归属于母公司股东的净利润(元) 2,901,461.74-195,322,353.9940,074,092.4451,950,756.0826,078,945.6345,757,944.5636,312,760.9930,088,115.3822,533,577.51
盈利能力:
 销售毛利率(%) 29.8720.4224.4825.2122.6622.2223.0824.7325.49
 销售净利率(%) -0.10-12.441.663.923.741.972.303.124.64
 净资产收益率(%) 0.06-3.950.791.030.53----
 总资产报酬率ROA(%) -0.01-3.510.801.040.45----
 投入资本回报率ROIC(%) 0.06-3.670.750.970.490.870.690.580.44
营运能力:
 存货周转率(次) 0.251.881.330.950.52----
 应收账款周转率(次) 2.2714.6910.726.803.42----
 总资产周转率(次) 0.050.310.260.190.10----
偿债能力:
 资产负债率(%) 12.5612.218.288.789.8513.7411.1710.4110.51
 股东权益比率(%) 87.9888.2692.0091.4090.2586.2688.7689.4889.14
 已获利息倍数(倍) 0.38-2,082.7712.8914.246.032.316.2114.418.54
 流动比率 2.782.874.364.233.932.883.653.893.85
 速动比率 1.511.692.052.061.861.611.922.112.18
发展能力:
 营业收入增长率(%) -49.57-4.679.7120.6328.28-16.32-16.694.5811.09
 营业利润增长率(%) -95.57-1,600.20-21.3120.30-10.61101.68-77.15-65.63-67.89
 税后利润增长率(%) -88.87-525.1210.3672.6615.73105.78-77.03-67.82-49.45
 净资产增长率(%) -4.93-4.260.472.703.804.11-13.30-13.77-16.66
 总资产增长率(%) -2.47-6.43-3.060.532.537.80-10.94-14.54-19.96

前瞻产业研究院